Search
BioVie Inc
BIVIAdd to Watchlist
1.630USD
0.0000.00%
Close 09-22 16:00（ET）
12.29MMarket Cap
LossP/E TTM
BioVie Inc (BIVI) Stock Price Target & Forecast
Analyst Rating
Based on 2 analysts giving stock ratings to BioVie Inc in the past month.
Buy
0 Strong Buy
2 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
5.255USD+222.39%
BIVI Analyst Recommendation Trends
In the current month, BIVI has received 2 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. BIVI average Analyst price target in the last month is 5.255.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
0
0
0
0
0
0
0
0
2
1
0
0
0
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
1
0
0
0
1
1
1
BIVI Analyst Rating for Peer Comparison
Updated: Sep 22, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
argenx SE
ARGX
11
14
3
0
0
28
Beigene Ltd
ONC
8
19
0
0
0
27
Ionis Pharmaceuticals Inc
IONS
6
14
6
0
0
26
Insmed Inc
INSM
7
17
0
0
0
24
IQVIA Holdings Inc
IQV
8
12
4
0
0
24
Kymera Therapeutics Inc
KYMR
8
13
2
0
0
23
Cytokinetics Inc
CYTK
4
16
2
0
0
22
CRISPR Therapeutics AG
CRSP
4
8
10
0
0
22
Revolution Medicines Inc
RVMD
8
13
1
0
0
22
Tempus AI Inc
TEM
5
7
7
1
1
21
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.81
-0.73
-0.52
Actual
-0.77
-0.70
-0.71
Surprise
+5.40%
+4.30%
-37.00%
FAQs
What is BioVie Inc's price target?
Analysts forecast that BioVie Inc's price target is USD 5.25, with the highest forecast at USD 5.51 and the lowest forecast at USD 5.00.
What is the analyst rating for BioVie Inc?
Based on the ratings of BioVie Inc's stock from 2 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.